|
Montero M, Rahimpour M, Viale AM, Almagro G, Eydallin G, Sevilla Á, Cánovas M, Bernal C, Lozano AB, Muñoz FJ, Baroja-Fernández E, Bahaji A, Mori H, Codoñer FM, Pozueta-Romero J. Systematic production of inactivating and non-inactivating suppressor mutations at the relA locus that compensate the detrimental effects of complete spot loss and affect glycogen content in Escherichia coli. PLoS One. 2014 Sep 4;9(9):e106938. doi: 10.1371/journal.pone.0106938. PubMed PMID: 25188023; PubMed Central PMCID: PMC4154780.
AÑO: 2014; IF: 3.234
|
25188023
|
Bernal V, Castaño-Cerezo S, Gallego-Jara J, Écija-Conesa A, de Diego T, Iborra JL, Cánovas M. Regulation of bacterial physiology by lysine acetylation of proteins. N Biotechnol. 2014 Dec 25;31(6):586-95. doi: 10.1016/j.nbt.2014.03.002. Review. PubMed PMID: 24636882.
AÑO: 2014; IF: 2.898
|
|
Cánovas M, Cabré F, Polonio F. Bioequivalence studies for 2 different strengths of irbesartan/hydrochlorothiazide combination in healthy volunteers: 300/25?mg and 300/12.5?mg film-coated tablets. Drug Res (Stuttg). 2014 May;64(5):257-62. doi: 10.1055/s-0033-1357179. PubMed PMID: 24105103.
AÑO: 2014
|
|
Arense P, Bernal V, Charlier D, Iborra JL, Foulquié-Moreno MR, Cánovas M. Metabolic engineering for high yielding L(-)-carnitine production in Escherichia coli. Microb Cell Fact. 2013 May 29;12:56. doi: 10.1186/1475-2859-12-56. PubMed PMID: 23718679; PubMed Central PMCID: PMC3680233.
AÑO: 2013; IF: 4.25
|
|
Rahimpour M, Montero M, Almagro G, Viale AM, Sevilla Á, Cánovas M, Muñoz FJ, Baroja-Fernández E, Bahaji A, Eydallin G, Dose H, Takeuchi R, Mori H, Pozueta-Romero J. GlgS, described previously as a glycogen synthesis control protein, negatively regulates motility and biofilm formation in Escherichia coli. Biochem J. 2013 Jun 15;452(3):559-73. doi: 10.1042/BJ20130154. PubMed PMID: 23537328.
AÑO: 2013; IF: 4.779
|